34.231.21.105
dgid:
enl:
npi:0
-Advertisement-
-Advertisement-

Lupus Nephritis

Anifrolumab well-tolerated in patients with systemic lupus erythematosus

Anifrolumab, a new strategy for the treatment of systemic lupus erythematosus, is well-tolerated and has a good safety profile, according to a meta-analysis and systematic review. After searching Embase, Cochrane, PubMed, and Web of Science databases for randomized controlled trials (RCTs) evaluating the safety of anifrolumab versus placebo in patients...

Read More
-Advertisement-
-Advertisement-
-Advertisement=-
-Advertisement-
-Advertisement-
-Advertisement=-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-